Intermountain’s quest upstream for value
“Intermountain Health’s CEO, Rob Allen, is leading the charge in shifting towards value-based care by focusing on alignment and simplicity within the healthcare
“Intermountain Health’s CEO, Rob Allen, is leading the charge in shifting towards value-based care by focusing on alignment and simplicity within the healthcare
Since the previous edition, we have added two chapters: Chapter 6 Intracranial monitoring and Chapter 8 Quantitative EEG. We have updated all nomenclature to adhere…
This systematic review and consensus statement reviews literature on the definition of neurological device abandonment and develops a consensus definition.
Learn from AMA member medical students about how easy it is to get involved, create change and bolster your advocacy and leadership credentials.
Since 2002, there has been a dramatic increase in suicide rates among US college athletes, making it the second-most common cause of death in this…
Dr Charles Raison, the Director of Clinical Research at the Usona Institute and Professor in the Department of Psychiatry at the University of Wisconsin–Madison, talks to…
Reshaping the drug war in one of Central America’s most lawless corners, the fentanyl boom has devastated the trade in opium poppies used to make…
Eosinophils are a rare immune cell subset with important roles in Th2 immunity and, recently, in cancer. Interleukin IL-33 (IL-33) is well recognized for its…
Cancer remains a formidable global health challenge, with metastasis being a key contributor to its lethality. Abundant high molecular mass hyaluronic acid, a major non-protein…
Ferroptosis is a cell death mechanism that has attracted significant attention as a potential basis for the development of new cancer therapies. Validation of ferroptosis…
Despite glutathione’s long-recognized role as a major cellular antioxidant and its central role in ferroptosis defense, inhibition of glutathione biosynthetic enzymes has received little attention…